AD-35
AD-35 is an orally active anti-Alzheimer's disease (AD) agent with moderate AChE inhibitory activity and metal ion chelating ability. AD-35 exhibits IC50 values for AChE and BuChE of 793 nM and 31428 nM, respectively. AD-35 can form chelates with Cu²⁺ and Fe³⁺, but its chelating ability for Zn²⁺ is relatively weak. AD-35 can inhibit Aβ aggregation and disassemble the formed Aβ aggregates, and inhibit Aβ-induced ERK phosphorylation. AD-35 inhibits neuroinflammation in AD rat models and demonstrates a strong effect in improving cognitive function[1].
Product Specifications
CAS Number
1531586-64-7
UNSPSC
12352005
Target
Amyloid-β; Cholinesterase (ChE) ; ERK; Interleukin Related; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway; Neuronal Signaling; Stem Cell/Wnt
Field of Research
Neurological Disease
Smiles
O=C(N(CCC1CCN(CC2=CC=CC=N2)CC1)C34CC4)C(C3=C5)=CC6=C5OCO6.OP(O)(O)=O
Molecular Formula
C24H30N3O7P
Molecular Weight
503.48
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AChE; IL-1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Phosphoinositide 3 Kinase, p85 beta (PI-3 Kinase p85 beta, PI3 Kinase p85 beta Subunit, PI3 Kinase p85 Subunit beta, PI3K, p85 beta, P85B, Phosphatidylinositol 3 Kinase Regulatory beta Subunit, Phosphatidylinositol 3 Kinase Regulatory Subunit beta, Phosph